英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
phyte查看　phyte　在百度字典中的解释百度英翻中〔查看〕
phyte查看　phyte　在Google字典中的解释Google英翻中〔查看〕
phyte查看　phyte　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • BioMarin Pharmaceutical | Global Biotechnology Company
    BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions Founded in 1997, we have a proven track record of innovation, with eight commercial therapies and a strong clinical and preclinical pipeline
  • BioMarin Pharmaceutical - Wikipedia
    BioMarin Pharmaceutical Inc is an American biotechnology company headquartered in San Rafael, California It has offices and facilities in the United States, South America, Asia, and Europe
  • BioMarin Pharmaceutical (BMRN) Stock Price, News Analysis
    BioMarin Pharmaceutical Inc is a biopharmaceutical company specializing in the development and commercialization of therapies for rare genetic and metabolic diseases
  • BMRN: BioMarin Pharmaceutical Inc Stock Price Quote - Bloomberg
    Stock analysis for BioMarin Pharmaceutical Inc (BMRN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile
  • BioMarin Pharmaceutical Inc. (BMRN) - Yahoo Finance
    Find the latest BioMarin Pharmaceutical Inc (BMRN) stock quote, history, news and other vital information to help you with your stock trading and investing
  • BioMarin Pharmaceutical Inc. - LinkedIn
    We transform lives through genetic discovery | Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery
  • BioMarin shares drop 4% as Voxzogo trials are discontinued
    BioMarin Pharmaceutical's (BMRN) shares fell on Monday after the company said it would discontinue dosing and enrollment in its phase 2 trials for Voxzogo in Turner syndrome, SHOX-deficiency, and
  • BioMarin pauses dosing and enrollment in two Voxzogo studies after . . .
    BioMarin has paused dosing and enrollment in two clinical trials of Voxzogo after safety concerns emerged The move follows reports of slipped capital femoral epiphysis events and comes amid rising competition from other companies developing treatments for achondroplasia
  • Trade BioMarin Pharmaceutical Inc - BMRN CFD - Capital. com
    Trade BioMarin Pharmaceutical Inc - BMRN CFD BioMarin Pharmaceutical (BMRN O) is an international producer of innovative biopharmaceuticals for rare genetic diseases The company’s developments provide significant advances for patients with rare, life-threatening diagnoses BioMarin introduces new treatments to the market, providing enormous help to adults and children with serious inherited
  • BioMarin Pharmaceutical | BMRN - Stock Price | Live Quote | Historical . . .
    BioMarin Pharmaceutical Inc is a biotechnology company The Company develops and commercializes pharmaceuticals for various diseases and medical conditions As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates





中文字典-英文字典  2005-2009